Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Leheurteur · SciRah

Researcher profile · Semantic Scholar

M. Leheurteur

Share profile

M. Leheurteur — researcher profile on SciRah

h-index: 26
Works: 147
Citations: 3,353

Most-cited papers

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
A. Darlix, G. Louvel, J. Fraisse, W. Jacot +22 more
2019British Journal of Cancer219 citations Open access
Semantic Scholar
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.
É. Deluche, A. Antoine, T. Bachelot, A. Lardy-Cléaud +23 more
2020European Journal of Cancer176 citations
Semantic Scholar
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
X. Pivot, G. Romieu, M. Debled, J. Pierga +330 more
2019The Lancet117 citations Open access
Semantic Scholar
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
B. You, Patrick Robelin, M. Tod, C. Louvet +19 more
2020Clinical Cancer Research115 citations Open access
Semantic Scholar
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
M. Lambertini, N. Olympios, J. Lequesne, C. Calbrix +7 more
2019Frontiers in Oncology65 citations Open access
Semantic Scholar
Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort.
D. Pasquier, A. Darlix, G. Louvel, J. Fraisse +23 more
2019European Journal of Cancer51 citations Open access
Semantic Scholar
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database
M. Carausu, M. Carton, A. Darlix, D. Pasquier +19 more
2021ESMO Open44 citations Open access
Semantic Scholar
Impact of body mass index on overall survival in patients with metastatic breast cancer
K. Saleh, M. Carton, V. Diéras, P. Heudel +22 more
2020Breast41 citations Open access
Semantic Scholar
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
F. Clatot, M. Fontanilles, L. Lefebvre, J. Lequesne +18 more
2020European Journal of Cancer38 citations Open access
Semantic Scholar
Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program
W. Jacot, P. Heudel, J. Fraisse, S. Gourgou +19 more
2019International Journal of Cancer34 citations Open access
Semantic Scholar
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France
Ombline de Calbiac, A. Lusque, A. Mailliez, T. Bachelot +16 more
2022JAMA Network Open33 citations Open access
Semantic Scholar
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial
I. Ray-Coquard, A. Savoye, C. Schiffler, M. Mouret-Reynier +20 more
2024Nature Communications26 citations Open access
Semantic Scholar
Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)
S. Thureau, V. Marchesi, M. Vieillard, L. Perrier +9 more
2021BMC Cancer24 citations Open access
Semantic Scholar
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
L. Zelek, P. Debourdeau, H. Bourgeois, J. Wagner +8 more
2021The Oncologist24 citations Open access
Semantic Scholar
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort
J. Hotton, A. Lusque, L. Leufflen, M. Campone +20 more
2021Annals of Surgery23 citations
Semantic Scholar
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2–14)
F. Penault-Llorca, F. Kwiatkowski, A. Arnaud, C. Lévy +17 more
2019Breast23 citations Open access
Semantic Scholar
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.
O. Le Saux, A. Lardy-Cléaud, S. Frank, M. Debled +20 more
2019European Journal of Cancer18 citations Open access
Semantic Scholar
Post‐traumatic stress symptomatology and adjustment of medical oncology practice during the COVID‐19 pandemic among adult patients with cancer in a day care hospital
F. Joly, O. Rigal, L. Guittet, S. Lefèvre-Arbogast +20 more
2021Cancer17 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
G. Ferron, G. de Rauglaudre, S. Becourt, N. Delanoy +28 more
2023Gynecologic Oncology16 citations
Semantic Scholar
238MO PROMENADE: PembROlizuMab for early triple negative ER-low breast caNcer, reAl worlD frEnch cohort
F. Cherifi, L. Cabel, C. Bousrih, E. Volant +16 more
2024Annals of Oncology13 citations
Semantic Scholar
Impact of preoperative staging with contrast-enhanced mammography for localized breast cancer management.
Fanny Montrognon, F. Clatot, A. Berghian, F. Douvrin +9 more
2022British Journal of Radiology12 citations Open access
Semantic Scholar
Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients
V. Allouchery, A. Perdrix, C. Calbrix, A. Berghian +7 more
2021Scientific Reports12 citations Open access
Semantic Scholar
Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy
A. Perdrix, N. Olympios, Jean Rouvet, M. Dégremont +5 more
2025Breast Cancer Research and Treatment11 citations Open access
Semantic Scholar
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database
A. Mailliez, V. D'Hondt, A. Lusque, O. Caron +18 more
2022International Journal of Cancer11 citations Open access
Semantic Scholar
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
M. Annonay, L. Gauquelin, R. Geiss, M. Ung +22 more
2021Breast10 citations Open access
Semantic Scholar
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma
Aurélien Drouyer, L. Beaussire, Pauline Jorda, M. Leheurteur +6 more
2023BMC Cancer9 citations Open access
Semantic Scholar
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study
A. Vasseur, M. Carton, S. Guiu, P. Augereau +18 more
2022Breast9 citations Open access
Semantic Scholar
Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study.
E. Bastien, Sophie Lefèvre-Arbogast, J. Lequesne, F. Gernier +19 more
2023The Journal of the National Comprehensive Cancer Network8 citations Open access
Semantic Scholar
291P HER2-low metastatic breast cancer (MBC): Management and prognosis of a new breast cancer entity in a real-world setting
J. Frenel, A. Lusque, A. Mailliez, T. Bachelot +16 more
2021Annals of Oncology8 citations Open access
Semantic Scholar
PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort
F. Cherifi, L. Cabel, C. Bousrih, E. Volant +22 more
2025ESMO Open7 citations Open access
Semantic Scholar
Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer
Ludivine Beaussire-Trouvay, O. Duhamel, A. Perdrix, É. Lévêque +7 more
2024Frontiers in Oncology7 citations Open access
Semantic Scholar
Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in France
Feriel Yahi, J. Lequesne, O. Rigal, A. Morel +6 more
2022Frontiers in Psychology7 citations Open access
Semantic Scholar
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
M. Frasca, Camille Sabathé, S. Delaloge, A. Galvin +21 more
2020European Journal of Cancer7 citations Open access
Semantic Scholar
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
L. Cabel, M. Carton, B. Cheaib, J. Pierga +19 more
2018Breast Cancer Research and Treatment7 citations
Semantic Scholar
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort
N. Epaillard, A. Lusque, W. Jacot, A. Mailliez +16 more
2024ESMO Open6 citations Open access
Semantic Scholar
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort
F. Moinard-Butot, C. Saint-Martin, C. Pflumio, M. Carton +20 more
2022Breast6 citations Open access
Semantic Scholar
Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO)
R. Leman, F. Cherifi, M. Leheurteur, P. Theret +23 more
2025BMC Cancer5 citations Open access
Semantic Scholar
Development of a ‘ready-to-use’ tool that includes preventability, for the assessment of adverse drug events in oncology
G. Hébert, F. Netzer, Sylvain Landry Kouakou, F. Lemare +30 more
2018International Journal of Clinical Pharmacy5 citations
Semantic Scholar
Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic.
F. Cherifi, F. Gernier, Fabrice Jardin, Sophie Lefèvre-Arbogast +18 more
2023Journal of Geriatric Oncology4 citations Open access
Semantic Scholar
Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study
M. Rogé, J. Salleron, Y. Kirova, M. Guigo +10 more
2022Cancers4 citations Open access
Semantic Scholar
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database
M. Carausu, M. Carton, L. Cabel, A. Patsouris +19 more
2020Therapeutic Advances in Medical Oncology4 citations Open access
Semantic Scholar
CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database
P. Gougis, M. Carton, C. Tchokothe, M. Campone +19 more
2019Breast3 citations Open access
Semantic Scholar
Management and outcome of metastatic breast cancer in men in the national multicenter observational ESME program.
J. Sirieix, J. Fraisse, S. Mathoulin-Pélissier, M. Leheurteur +15 more
2018Annals of Oncology3 citations Open access
Semantic Scholar
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial.
Laetitia Collet, M. Ardin, D. Venet, Justine Berthet +17 more
2025Clinical Cancer Research2 citations
Semantic Scholar
Post-traumatic stress symptoms in cancer patients during the COVID-19 pandemic: a one-year longitudinal study
E. Bastien, Sophie Lefèvre-Arbogast, J. Lequesne, F. Gernier +19 more
2022medRxiv2 citations Open access
Semantic Scholar
Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME)
J. Sirieix, J. Fraisse, S. Mathoulin-Pélissier, M. Leheurteur +18 more
2020Therapeutic Advances in Medical Oncology2 citations Open access
Semantic Scholar
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer
F. Lynce, C. Valenza, S. Niman, F. Bertucci +35 more
2026ESMO Open1 citations Open access
Semantic Scholar
BRCA pathogenic variants and response in early TNBC patients treated with neoadjuvant pembrolizumab: outcomes of the BRCAPATH study
B. Popescu, L. Simon, Céline Blaye, S. Marchi +8 more
2026Breast Cancer1 citations
Semantic Scholar
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)
R. Vion, C. Calbrix, A. Berghian, É. Lévêque +9 more
2025Clinical and Translational Oncology1 citations
Semantic Scholar
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort
L. Collet, Lauriane Eberst, Gaut Ludovic, M. Debled +17 more
2023Breast Cancer1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Uwer×22
Invite
L. Uwer — researcher profile on SciRah
A. Gonçalves×20
Invite
A. Gonçalves — researcher profile on SciRah
M. Mouret-Reynier×18
Invite
M. Mouret-Reynier — researcher profile on SciRah
T. Petit×18
Invite
T. Petit — researcher profile on SciRah

×17

Invite

J. Ferrero — researcher profile on SciRah

Invite

F. Dalenc — researcher profile on SciRah

Invite

M. Debled — researcher profile on SciRah

Invite

C. Lévy — researcher profile on SciRah

T. Bachelot×14

Invite

T. Bachelot — researcher profile on SciRah

C. Jouannaud×12

Invite

C. Jouannaud — researcher profile on SciRah

C. Courtinard×10

Invite

C. Courtinard — researcher profile on SciRah

J. Lequesne×10

Invite

J. Lequesne — researcher profile on SciRah